21 November 2017 - Australian cancer patients are waiting twice as long those overseas to get access to life saving new treatments because we take too long to approve new biomarker tests for the medicines.

A major report by cancer experts will today call for the bureaucratic red tape to be cut and the nation’s medicines watchdog to take over the job of approving both the medicines and the blood tests.

Former cancer Council chief Professor Ian Olver, now from University of South Australia’s Sansom Institute for Health Research, said this would speed up access to treatment.

Read Herald Sun article